Meta-analysis of six RCTs in major depressive disorder: standard-dose psilocybin reduced depressive symptoms vs control (SMD -1.05, 4 trials; high heterogeneity) but raised headache and nausea, which resolved; low-dose psilocybin showed no benefit.
Meta-analysisn = 6 trials
Kishi et al. Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis